Intramedullary tumors are the tumors which are present in the spinal cord, i.e., inside the pial covering and substance of the spinal cord itself.
Gliomatous and nongliomatous tumors constitute 90 and 10% respectively.
In 75% cases, the astrocytmas extend over 4 or less 4 vertebral segments. In some cases the lesions extends throughout the spinal cord, for example holocord astrocytomas.
Half of the central nervous system ependymomas are located in the spinal cord and, of these, 50% are located in the filum terminale. The next common site is the cervical cord.
Glioblastomas are not common.
Hemangioblastoms are rare, consist of less than 2% of primary spinal cord tumors.
Clinical presentation depends upon the site and size of the lesion.
MRI of spine with contrast is the investigation of choice.
Intraoperative image of my adult patient where tumor is seen after posterior midline myelotomy. Histopathology of the tumor was suggestive of Pilocytic astrocytoma ( WHO grade 1 tumor)
The operating microscope, bipolar coagulators, intraoperative physiological monitoring ( somatosensory evoked potenial monitoring, motor evoked potential ) , microscissors, microdissectors, small tumor holding forceps, Cavitron Ultrasonic Surgical Aspirators (CUSA) , intraoperative USG ( Ultrasonography) are good for safe excision of intramedullary lesions.
This diagram explains the location of the intramedullay tumors. Piamater is the innermost of three meninges ( Duramater, Arachnoid and Piamater). It covers the spinal cord. So the tumors outside of it may be IDEM ( intradural extramedullary) or extradural lesions.
Intramedullary tumors constitute about 35-40% of all intraspinal tumors in children. In children intramedullary tumors are mainly developmental in origin, like dermoid, lipoma and epidermoid). In adults intramedullary tumors may arise later in life, like astrocytoma, ependymoma and hemangioblastoma.
Spinal tumors are are classified as
(1)
extradural,
(2) intradural extramedullary, and
(3)
intradural intramedullary.
Extradural tumors are the most common spinal
tumors and are usually of metastatic origin.
Intradural Extramedullary (IDEM) tumors are mainly neurofibroma and meningioma.
Intradural intramedullary lesions comprise 20 to 30% of all primary spinal cord tumors.
Intradural Extramedullary (IDEM) tumors are mainly neurofibroma and meningioma.
Intradural intramedullary lesions comprise 20 to 30% of all primary spinal cord tumors.
Gliomas make up 80% of all intramedullary
tumors. The gliomas are further subdivided into astrocytomas (60 to 70%) and
ependymomas (30 to 40%). Hemangioblastomas
are the third most frequent intramedullary spinal cord (IMSC) tumors, comprising 2 to 15% of all
intramedullary tumors. Metastatic intramedullary tumors are rare but
present in 2% of all intramedullary tumors. Lipomas are commonly associated with spinal dysraphism.
Gliomatous and nongliomatous tumors constitute 90 and 10% respectively.
In 75% cases, the astrocytmas extend over 4 or less 4 vertebral segments. In some cases the lesions extends throughout the spinal cord, for example holocord astrocytomas.
Half of the central nervous system ependymomas are located in the spinal cord and, of these, 50% are located in the filum terminale. The next common site is the cervical cord.
Glioblastomas are not common.
Hemangioblastoms are rare, consist of less than 2% of primary spinal cord tumors.
Clinical presentation depends upon the site and size of the lesion.
MRI of spine with contrast is the investigation of choice.
Intraoperative image of my adult patient where tumor is seen after posterior midline myelotomy. Histopathology of the tumor was suggestive of Pilocytic astrocytoma ( WHO grade 1 tumor)
The operating microscope, bipolar coagulators, intraoperative physiological monitoring ( somatosensory evoked potenial monitoring, motor evoked potential ) , microscissors, microdissectors, small tumor holding forceps, Cavitron Ultrasonic Surgical Aspirators (CUSA) , intraoperative USG ( Ultrasonography) are good for safe excision of intramedullary lesions.
References
Samartzis D,
Gillis CC, Shih P, O'Toole JE, Fessler RG. Intramedullary Spinal Cord Tumors:
Part I-Epidemiology, Pathophysiology, and Diagnosis. Global Spine J. 2015;5(5):425-35. And references as numbered
below
Mechtler L L, Nandigam K. Spinal cord tumors: new
views and future directions. Neurol Clin. 2013;31(1):241–268.
Grimm S, Chamberlain M C. Adult primary spinal cord
tumors. Expert Rev Neurother. 2009;9(10):1487–1495.
DeSousa A L, Kalsbeck J E, Mealey J Jr, Campbell R
L, Hockey A. Intraspinal tumors in children. A review of 81 cases. J Neurosurg.
1979;51(4):437–445.
Mandigo C E, Ogden A T, Angevine P D, McCormick P
C. Operative management of spinal hemangioblastoma. Neurosurgery. 2009;65(6):1166–1177.
Ravi Ramamurthy. Spinal Intramedullary Tumours. Chapter 130, Volume 2, in Textbook of Operative Neurosurgery, B.I Publications Tvt Ltd, New Delhi, Pages1107-1113.
Ravi Ramamurthy. Spinal Intramedullary Tumours. Chapter 130, Volume 2, in Textbook of Operative Neurosurgery, B.I Publications Tvt Ltd, New Delhi, Pages1107-1113.
I'm 55-year-old from Paris, I was diagnosed with second-stage liver cancer following a scheduled examination to monitor liver cirrhosis. I had lost a lot of weight. A CT scan revealed three tumors; one in the center of my liver in damaged tissue and two in healthy portions of my liver. No chemotherapy or radiotherapy treatment was prescribed due to my age, the number of liver tumors. One month following my diagnosis I began taking 12 (350 point) Salvestrol supplements per day, commensurate with my body weight. This comprised six Salvestrol Shield (350 point) capsules and six Salvestrol Gold (350 point) capsules, spread through the day by taking two of each capsule after each main meal. This level of Salvestrol supplementation (4,000 points per day) was maintained for four months. In addition, I began a program of breathing exercises, chi exercises, meditation, stretching and stress avoidance. Due to the variety of conditions that I suffered from, I received ongoing medical examinations. Eleven months after commencing Salvestrol supplementation But all invalid so I keep searching for a herbal cure online that how I came across a testimony appreciating Dr Itua on how he cured her HIV/Herpes, I contacted him through email he listed above, Dr Itua sent me his herbal medicine for cancer to drink for two weeks to cure I paid him for the delivering then I received my herbal medicine and drank it for two weeks and I was cured until now I'm all clear of cancer, I will advise you to contact Dr Itua Herbal Center On Email...drituaherbalcenter@gmail.com. WhatsApps Number...+2348149277967. If you are suffering from Diseases listed below,
ReplyDeleteCancer
HIV/Aids
Herpes Virus
Bladder cancer
Brain cancer
Colon-Rectal Cancer
Breast Cancer
Prostate Cancer
Esophageal cancer
Gallbladder cancer
Gestational trophoblastic disease
Head and neck cancer
Hodgkin lymphoma
Intestinal cancer
Kidney cancer
Leukemia
Liver cancer
Lung cancer
Melanoma
Mesothelioma
Multiple myeloma
Neuroendocrine tumors
Non-Hodgkin lymphoma
Oral cancer
Ovarian cancer
Sinus cancer
Skin cancer
Soft tissue sarcoma
Spinal cancer
Stomach cancer
Testicular cancer
Throat cancer
Thyroid Cancer
Uterine cancer
Vaginal cancer
Vulvar cancer
Hepatitis
Chronic Illness
Lupus
Diabetes
HPV
Fibromyalgia.